Novavax
NVAX
190 hedge funds and large institutions have $1.39B invested in Novavax in 2015 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 78 increasing their positions, 43 reducing their positions, and 18 closing their positions.
178% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 18
81% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 43
19% more funds holding
Funds holding: 159 → 190 (+31)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
24% less call options, than puts
Call options by funds: $16.1M | Put options by funds: $21.1M
32% less capital invested
Capital invested by funds: $2.05B → $1.39B (-$657M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$51M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$20.2M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$16.2M |
| 4 |
Millennium Management
New York
|
+$15.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
-$41.8M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$29.1M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$26.1M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$14.2M |
| 5 |
BNP Paribas Asset Management
Paris,
France
|
-$5.99M |
NVAX Hedge Fund Activity: Q3 2015 in Review
190 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q3 2015, worth a combined $1.39B — down 32% from $2.05B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new NVAX positions and 18 closed out — a net gain of 32 holders — while 78 added to existing stakes and 43 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $51M. The largest seller was First Trust Advisors, cutting an estimated $41.8M.
- 190 institutional investors held Novavax (NVAX) as of Q3 2015, up from 159 in Q2 2015.
- Funds reported $1.39B of Novavax stock for Q3 2015, down 32% quarter-over-quarter.
- 50 funds opened new Novavax positions in Q3 2015 and 18 closed out, a net change of +32 holders.
- The largest Novavax buyer in Q3 2015 was Fidelity Investments, an estimated $51M added.
- The largest Novavax seller in Q3 2015 was First Trust Advisors, an estimated $41.8M sold.
Based on aggregated 13F filings for Q3 2015.